IDiyas

For the Inventor, By the Inventor

Kagoshima, Japan

Shin Nippon Biomedical Laboratories, Ltd.


USPTO Granted Patents = 35



Trademarks = 8

Forward Citations = 267

Loading Chart...
Loading Chart...

26 inventors (with patents filed for the assignee):

goldMedal Shunji Haruta (19 out of 21 patents)

silverMedal Ryoichi Nagata (16 out of 16 patents)

bronzeMedal Tatsuo Tsutsui (6 out of 15 patents)

4.  Takefumi Gemba (4 out of 9 patents)

5.  Hidetoshi Yamashita (2 out of 2 patents)

6.  Nobuyuki Suzuki (2 out of 2 patents)

7.  Takashi Hanafusa (2 out of 4 patents)

8.  Toshikazu Oki (2 out of 61 patents)

9.  Genji Satoyoshi (2 out of 2 patents)

10.  Hideaki Mishima (2 out of 2 patents)

11.  Yutaka Kawakami (1 out of 11 patents)

12.  Yusuke Torikai (1 out of 1 patent)

13.  Ikumi Shiga (1 out of 1 patent)

14.  Masatoshi Kashima (1 out of 1 patent)

15.  Hiroaki Magotani (1 out of 1 patent)


35 patents:

1. 12478581 - Powder formulation for intranasal administration, and manufacturing method thereof (2025-11-25),
2. 12343472 - Powder preparation, cartridge, and device (2025-07-01),
3. 12246130 - Medicine dispensing device and method for manufacturing same (2025-03-11),
4. 12137706 - Micro-encapsulated aquaculture feed (2024-11-12),
5. 12102754 - Intranasal delivery devices (2024-10-01),
6. 11872314 - Pharmaceutical compositions (2024-01-16),
7. 11744967 - Intranasal delivery devices (2023-09-05),
8. 11559640 - Medicine storage cartridge with nozzle, sprayer therefor, and powdered medicine dispensing device for nasal cavity (2023-01-24),
9. 11311615 - Vaccine compositions (2022-04-26),
10. 10792253 - Pharmaceutical compositions (2020-10-06),
11. 10463723 - Methods and compositions for intranasal delivery (2019-11-05),
12. 10322173 - Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent (2019-06-18),
13. 10293123 - Test substance administration system for animal experiment (2019-05-21),
14. 10195139 - Preparation for transnasal application (2019-02-05),
15. 10149905 - Chiral nucleic acid adjuvant having antitumor effect and antitumor agent (2018-12-11),
Shin Nippon Biomedical Laboratories, Ltd. is a leading contract research organization (CRO) specializing in preclinical and early phase clinical studies. With over 30 years of experience, we offer a wide range of services to support pharmaceutical and biotechnology companies in drug development. Our state-of-the-art facilities, experienced scientists, and dedication to quality ensure reliable and timely results. We are committed to advancing medical research and improving human health through our innovative solutions.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

35 Patents

#3 in Kagoshima

#2,073 in Japan

#18,571 in the World

...
Kagoshima, Japan

Shin Nippon Biomedical Laboratories, Ltd.

Forward Citations = 267

26 inventors:

goldMedal Shunji Haruta (19 out of 21 patents)

silverMedal Ryoichi Nagata (16 out of 16 patents)

bronzeMedal Tatsuo Tsutsui (6 out of 15 patents)

4.  Takefumi Gemba (4 out of 9 patents)

5.  Hidetoshi Yamashita (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com
Loading…